bacitracin-a and Meningitis--Pneumococcal

bacitracin-a has been researched along with Meningitis--Pneumococcal* in 1 studies

Other Studies

1 other study(ies) available for bacitracin-a and Meningitis--Pneumococcal

ArticleYear
Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG
    Drug delivery, 2018, Volume: 25, Issue:1

    Pneumococcal meningitis (PM), caused by Streptococcus pneumonia, remains a high-burden disease in developing countries. Antibiotic therapy has been limited due to the inefficiency of drug transport across the blood-brain barrier (BBB) and the emergence of drug-resistant strains. In our preliminary study, PEGylated nano-self-assemblies of bacitracin A (PEGylated Nano-BA

    Topics: Animals; Anti-Bacterial Agents; Bacitracin; Brain; Drug Compounding; Drug Delivery Systems; Drug Resistance, Bacterial; Male; Meningitis, Pneumococcal; Mice; Micelles; Microbial Sensitivity Tests; Nanoparticles; Penicillins; Peptide Fragments; Poloxamer; Polyethylene Glycols; Streptococcus pneumoniae; Tissue Distribution; Viral Envelope Proteins

2018